Zoetis | ZTS - Debt




Zoetis reported $6.57B in Debt for its fiscal quarter ending in December of 2024.

Debt Change Date
AbbVie USD 71.08B 445M Sep/2024
Align Technology USD 0 129.09M Sep/2024
Bayer EUR 41.16B 5.42B Sep/2024
Bristol-Myers Squibb USD 49.65B 103M Dec/2024
Charles River Laboratories USD 2.24B 89.65M Dec/2024
Dentsply International USD 2.22B 5M Sep/2024
Eli Lilly USD 31.12B 2.23B Sep/2024
Henry Schein USD 2.65B 185M Sep/2024
Idexx Laboratories USD 867.57M 6.32M Dec/2024
Illumina USD 1.99B 1000K Dec/2024
IQVIA Holdings USD 13.98B 471M Dec/2024
J&J USD 35.75B 5.74B Sep/2024
Laboratory Of America USD 6.41B 421.6M Dec/2024
Merck USD 38.13B 343M Sep/2024
Neogen USD 892.44M 663K Nov/2024
Pacira USD 644.42M 4.17M Sep/2024
Patterson Companies USD 812.56M 128.16M Oct/2024
Perrigo USD 4.75B 695.7M Sep/2024
Pfizer USD 66.62B 2.06B Sep/2024
Quest Diagnostics USD 6.22B 753M Dec/2024
Sanofi 23.75B 5.33B Jun/2024
Sanofi 23.75B 5.33B Jun/2024
Zoetis USD 6.57B 185M Dec/2024